Tonix Pharmaceuticals Holding (TNXP) Free Cash Flow (2023 - 2025)
Historic Free Cash Flow for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$29.7 million.
- Tonix Pharmaceuticals Holding's Free Cash Flow fell 5812.87% to -$29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.3 million, marking a year-over-year decrease of 1030.78%. This contributed to the annual value of -$61.0 million for FY2024, which is 4445.3% up from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Free Cash Flow stood at -$29.7 million for Q3 2025, which was down 5812.87% from -$15.4 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Free Cash Flow ranged from a high of -$9.9 million in Q2 2024 and a low of -$36.7 million during Q1 2023
- In the last 3 years, Tonix Pharmaceuticals Holding's Free Cash Flow had a median value of -$18.8 million in 2024 and averaged -$21.1 million.
- As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Free Cash Flow surged by 6065.76% in 2024, and later tumbled by 5812.87% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Free Cash Flow (Quarter) stood at -$22.8 million in 2023, then surged by 35.76% to -$14.6 million in 2024, then plummeted by 103.27% to -$29.7 million in 2025.
- Its last three reported values are -$29.7 million in Q3 2025, -$15.4 million for Q2 2025, and -$16.6 million during Q1 2025.